Global Tyrosine Kinase Inhibitors Market Data Survey Report 2025

January 2018 | 67 pages | ID: G63D95F6E56EN
HeyReport

Abstracts

SUMMARY

The global Tyrosine Kinase Inhibitors market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:

Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:

• AstraZeneca
• Pfizer
• Novartis
• Bristol-Myers Squibb
• Bayer
• Boehringer Ingelheim International
• Boehringer Ingelheim International
• Johnson & Johnson
• Eisai

Major applications as follows:

• Chronic Myeloid Leukemia (CML)
• Lung Cancer
• Breast Cancer
• Renal Cell Cancer
• Others

Major Type as follows:

• BCR-ABL Tyrosine Kinase Inhibitor
• Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
• Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors

Regional market size, production data and export & import:

• Asia-Pacific
• North America
• Europe
• South America
• Middle East & Africa

Contents

1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 AstraZeneca
  3.1.2 Company Information
  3.1.2 Product Specifications
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Pfizer
  3.2.1 Company Information
  3.2.2 Product Specifications
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Novartis
  3.3.1 Company Information
  3.3.2 Product Specifications
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Bristol-Myers Squibb
  3.4.1 Company Information
  3.4.2 Product Specifications
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Bayer
  3.5.1 Company Information
  3.5.2 Product Specifications
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Boehringer Ingelheim International
  3.6.1 Company Information
  3.6.2 Product Specifications
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Boehringer Ingelheim International
  3.7.1 Company Information
  3.7.2 Product Specifications
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Johnson & Johnson
  3.8.1 Company Information
  3.8.2 Product Specifications
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Eisai
  3.9.1 Company Information
  3.9.2 Product Specifications
  3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 MAJOR APPLICATION

4.1 Chronic Myeloid Leukemia (CML)
  4.1.1 Overview
  4.1.2 Chronic Myeloid Leukemia (CML) Market Size and Forecast
4.2 Lung Cancer
  4.2.1 Overview
  4.2.2 Lung Cancer Market Size and Forecast
4.3 Breast Cancer
  4.3.1 Overview
  4.3.2 Breast Cancer Market Size and Forecast
4.4 Renal Cell Cancer
  4.4.1 Overview
  4.4.2 Renal Cell Cancer Market Size and Forecast
4.5 Others
  4.5.1 Overview
  4.5.2 Others Market Size and Forecast

5 MARKET BY TYPE

5.1 BCR-ABL Tyrosine Kinase Inhibitor
  5.1.1 Overview
  5.1.2 BCR-ABL Tyrosine Kinase Inhibitor Market Size and Forecast
5.2 Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
  5.2.1 Overview
  5.2.2 Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Market Size and Forecast
5.3 Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors
  5.3.1 Overview
  5.3.2 Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors Market Size and Forecast

6 CONCLUSION

List Of Tables

LIST OF TABLES

Tab Regional Production 2011-2017 (Million USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Volume, Price, Cost and Margin of Novartis
Tab Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Tab Sales Revenue, Volume, Price, Cost and Margin of Bayer
Tab Sales Revenue, Volume, Price, Cost and Margin of Boehringer Ingelheim International
Tab Sales Revenue, Volume, Price, Cost and Margin of Boehringer Ingelheim International
Tab Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson
Tab Sales Revenue, Volume, Price, Cost and Margin of Eisai

List Of Figures

LIST OF FIGURES

Fig Global Tyrosine Kinase Inhibitors Market Size and CAGR 2011-2017 (Million USD)
Fig Global Tyrosine Kinase Inhibitors Market Size and CAGR 2011-2017 (Volume)
Fig Global Tyrosine Kinase Inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Tyrosine Kinase Inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Fig Chronic Myeloid Leukemia (CML) Market Size and CAGR 2011-2017 (Million USD)
Fig Chronic Myeloid Leukemia (CML) Market Size and CAGR 2011-2017 (Volume)
Fig Chronic Myeloid Leukemia (CML) Market Forecast and CAGR 2018-2025 (Million USD)
Fig Chronic Myeloid Leukemia (CML) Market Forecast and CAGR 2018-2025 (Volume)
Fig Lung Cancer Market Size and CAGR 2011-2017 (Million USD)
Fig Lung Cancer Market Size and CAGR 2011-2017 (Volume)
Fig Lung Cancer Market Forecast and CAGR 2018-2025 (Million USD)
Fig Lung Cancer Market Forecast and CAGR 2018-2025 (Volume)
Fig Breast Cancer Market Size and CAGR 2011-2017 (Million USD)
Fig Breast Cancer Market Size and CAGR 2011-2017 (Volume)
Fig Breast Cancer Market Forecast and CAGR 2018-2025 (Million USD)
Fig Breast Cancer Market Forecast and CAGR 2018-2025 (Volume)
Fig Renal Cell Cancer Market Size and CAGR 2011-2017 (Million USD)
Fig Renal Cell Cancer Market Size and CAGR 2011-2017 (Volume)
Fig Renal Cell Cancer Market Forecast and CAGR 2018-2025 (Million USD)
Fig Renal Cell Cancer Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig BCR-ABL Tyrosine Kinase Inhibitor Market Size and CAGR 2011-2017 (Million USD)
Fig BCR-ABL Tyrosine Kinase Inhibitor Market Size and CAGR 2011-2017 (Volume)
Fig BCR-ABL Tyrosine Kinase Inhibitor Market Forecast and CAGR 2018-2025 (Million USD)
Fig BCR-ABL Tyrosine Kinase Inhibitor Market Forecast and CAGR 2018-2025 (Volume)
Fig Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Market Size and CAGR 2011-2017 (Million USD)
Fig Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Market Size and CAGR 2011-2017 (Volume)
Fig Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Fig Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Fig Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors Market Size and CAGR 2011-2017 (Million USD)
Fig Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors Market Size and CAGR 2011-2017 (Volume)
Fig Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Fig Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors Market Forecast and CAGR 2018-2025 (Volume)